The suspension of Chiron's licence for the manufacture of Fluvirin has been lifted by UK MHRA recently.

According to the release, MHRA inspectors have been working closely alongside the company since the manufacturing licence required to produce the vaccine was suspended towards the end of 2004, following problems with the manufacturing plant and process. The MHRA inspectors have concluded that satisfactory progress has been made in the manufacturing areas which had previously caused concern.

Their findings were considered at the MHRA's Inspections Action Group (IAG) on 1st March 2005, and the IAG's recommendation to lift the suspension was accepted by the MHRA on the same day.

The company has been informed, and is now free to recommence full manufacturing of the vaccine, the release stated.